Fibromyalgia and drugs of ingredients of carbamazepine (a real world drug study)
Summary:
Fibromyalgia is found among people who take drugs with ingredients of carbamazepine, especially for people who are female, 40-49 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 88,731 people who have side effects when taking drugs with ingredients of carbamazepine from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Carbamazepine, Carbatrol, Carnexiv, Epitol, Equetro, Tegretol, Tegretol-xr, Teril.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
88,731 people reported to have side effects when taking drugs with ingredients of carbamazepine.
Among them, 214 people (0.24%) have Fibromyalgia
What is Fibromyalgia?
Fibromyalgia (a long-term condition which causes pain all over the body) is found to be associated with 1,335 drugs and 1,836 conditions by eHealthMe. Check the latest studies of Fibromyalgia.
Number of reports submitted per year:

Time on drugs with ingredients of carbamazepine when people have Fibromyalgia *:
- < 1 month: 75.0 %
- 1 - 6 months: 12.5 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 6.25 %
- 5 - 10 years: 0.0 %
- 10+ years: 6.25 %
Gender of people who have Fibromyalgia when taking drugs with ingredients of carbamazepine *:
- female: 88.15 %
- male: 11.85 %
Age of people who have Fibromyalgia when taking drugs with ingredients of carbamazepine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 4.79 %
- 20-29: 0.6000000000000001 %
- 30-39: 10.18 %
- 40-49: 37.13 %
- 50-59: 21.56 %
- 60+: 25.75 %
Conditions people have *:
You may use this to check any potential undetected conditions.
Other drugs people take *:
You may use this to check any potential interacting drugs.
Other side effects people have besides Fibromyalgia *:
You may use this to check any potential undetected side effects.
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
- Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
- Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
- Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
- Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
- Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
Related studies
Drugs with ingredients of carbamazepine, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on carbamazepine. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Premarin for Menopause? - 4 seconds ago
- Could Zovirax cause Blood Urea Nitrogen/Creatinine Ratio Increased? - 4 seconds ago
- Cephalexin and Dexamethasone drug interactions for boys aged 10-19 - 4 seconds ago
- Drug interactions of Sonata and Axert - 5 seconds ago
- Could Levothroid cause Photosensitivity Reaction? - 5 seconds ago
- Lantus Solostar vs. Fortamet, side effect and effectiveness comparison - 8 seconds ago
- Ampyra and Slurred Speech for Women aged 50-59 - 23 seconds ago
- Ampyra and Language Impairment for Women aged 50-59 - 24 seconds ago
- Ampyra and Inability To Speak for Women aged 50-59 - 24 seconds ago
- Ampyra and Impairment Of Speech for Women aged 50-59 - 24 seconds ago